tiprankstipranks
Helus Pharma (HELP)
NASDAQ:HELP
US Market
HELP
Helus Pharma
RESEARCH TOOLSreports

Helus Pharma (HELP) Financial Statements

2,512 Followers

Helus Pharma Financial Overview

Helus Pharma's market cap is currently $1.37M. The company's EPS TTM is $-5.01; its P/E ratio is -1.72; Helus Pharma is scheduled to report earnings on June 29, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 26Jun 25Mar 24Mar 23Mar 22
Income Statement
Total Revenue$ -44.68MC$ 472.27KC$ 0.00C$ 251.01KC$ 167.76K
Gross Profit$ -44.80MC$ 0.00C$ 0.00C$ 0.00C$ 0.00
Operating Income$ -141.68MC$ -143.15MC$ -78.84MC$ -51.52MC$ -63.84M
EBITDA$ -141.56MC$ -142.94MC$ -78.41MC$ -51.27MC$ -63.67M
Net Income$ -147.05MC$ -113.14MC$ -78.08MC$ -47.49MC$ -67.63M
Balance Sheet
Cash & Short-Term Investments$ 157.78MC$ 135.02MC$ 208.99MC$ 16.63MC$ 53.64M
Total Assets$ 251.98MC$ 258.62MC$ 302.02MC$ 53.90MC$ 84.06M
Total Debt$ 0.00C$ 0.00C$ 291.00KC$ 0.00C$ 0.00
Net Debt$ -157.78MC$ -135.02MC$ -208.70MC$ -16.63MC$ -53.64M
Total Liabilities$ 19.44MC$ 21.42MC$ 10.10MC$ 5.66MC$ 7.91M
Stockholders' Equity$ 232.24MC$ 237.20MC$ 291.93MC$ 48.23MC$ 76.16M
Cash Flow
Free Cash Flow$ -133.79MC$ -103.27MC$ -69.62MC$ -50.74MC$ -45.73M
Operating Cash Flow$ -132.42MC$ -101.30MC$ -68.91MC$ -47.43MC$ -45.21M
Investing Cash Flow$ -1.35MC$ -1.97MC$ 6.92MC$ -3.31MC$ -770.00K
Financing Cash Flow$ 196.97MC$ 20.20MC$ 254.51MC$ 13.56MC$ 35.78M

Helus Pharma Earnings and Revenue History

Income Statement >

Helus Pharma Debt to Assets

Balance Sheet >

Helus Pharma Cash Flow

Cash Flow >

Helus Pharma Forecast EPS vs Actual EPS

Earnings >